Baxter (NYSE: BAX) reported Q4 EPS of $1.04, $0.01 better than the analyst estimate of $1.03. Revenue for the quarter came in at $3.5 billion versus the consensus estimate of $3.35 billion.

GUIDANCE:

Baxter sees FY2022 EPS of $4.25-$4.35, versus the consensus of $4.36.

For earnings history and earnings-related data on Baxter (BAX) click here.